The Food and Drug Administration conducts annual inspections of about 7 percent of overseas drugmakers that ship to the United States, suggesting it would take 13 years to visit them all, a government investigator said.

Some of the drugmakers may have never been inspected, and the exact numbers are unclear, said Marcia Crosse, director of health care for the Government Accountability Office, the investigative arm of Congress, at a House hearing today.